Grown Rogue International (GRUSF) Total Debt Growth (1y) (2010 - 2025)
Grown Rogue International (GRUSF) Total Debt Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -11.90% |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -0.14% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 37.52% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -10.56% |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -9.53% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -13.33% |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 922,180,181.77% |
| Jun 30, 2025 | 458.08% |
| Apr 30, 2021 | 99.64% |
| Oct 31, 2020 | 433.21% |
| Jul 31, 2020 | 871.71% |
| Apr 30, 2020 | 1,070.38% |
| Oct 31, 2019 | 200.00% |
| Apr 30, 2019 | 0.00% |
| Oct 31, 2018 | -90.04% |
| May 31, 2018 | -55.65% |
| Feb 28, 2018 | 38.88% |
| Nov 30, 2015 | 90.84% |
| Aug 31, 2015 | -80.67% |
| May 31, 2015 | 3,911.55% |
| Feb 28, 2015 | -146.98% |
| Nov 30, 2014 | -145.11% |
| Aug 31, 2014 | 642.18% |
| May 31, 2014 | -98.77% |
| Feb 28, 2014 | -19.72% |
| Nov 30, 2013 | 15,358.32% |